InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.45
(
0.51%
)
Bitcoin
62,301.42
(
-1.36%
)
Post# of 252311
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: None

Friday, 08/19/2016 11:57:02 AM

Friday, August 19, 2016 11:57:02 AM

Post# of 252311
GILD analysts opposing views

I thought this interesting. Basically Piper's Joshua Schimmer thinks spinning off HCV and/or HIV is value destructive while RBC's Michael Yee and Jefferies' Brian Abrahams think it could unlock value

http://thefly.com/landingPageNews.php?id=2420781&headline=GILD;BIIB;BMRN-Piper-says-splitting-Gilead-businesses-a-poor-idea
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up